Immediate Support Available for Your Trials in Accordance With New COVID 19 Guidance

In these unprecedented times, we at Precision remain resolute in our commitment to supporting the critical work you do. Our goal is to help you continue your cutting edge clinical research without interruption.

Last week, new guidance was for the conduct of clinical trials of medical products in direct response to the COVID 19 pandemic. Unanticipated study challenges include site closures, travel limitation , and supply chain interruptions, all potentially impacting the conduct of clinical trials. This guidance is good news as it provides sponsors
general considerations to assist in assuring the safety of trial participants, in a GCP compliant environment, while mitigating risk in trial integrity. Recognising there may be a time sensitive need to seamlessly implement new processes in real time, Precision can share our resources to help ensure the conduct of your program during this critical time.

Here’s how Precision can support you:

1. Labs—on-line and ready

Our 6 laboratories in Europe and United States remain open and fully operational. Appropriate environmental accommodations have been implemented to ensure the safety of our staff and continuous operations. In addition, extended laboratory service hours are in place to support your program needs.

2. Global PBMC and sample processing for your samples

The reallocation of key hospital staff to accommodate COVID-19 testing has impacted healthcare providers’ ability to maintain protocols around handling of specimens. To minimise this burden, we have increased the receiving and processing capacity of our labs, and we are prepared to assume this responsibility for your study with the seamless transition of specimens.

3. Biorepository to manage your study assets

As medical centers and testing laboratories institute emergency access and procedures, the logistics and management of your study specimens may be re-prioritised. Leverage our biospecimen logistics and biobanking services to ensure your study specimens are managed according to your protocol.

4. Scientists to support the progress of your work

Evolving site monitoring restrictions and shipping disruptions increase unpredictability for trials. Precision’s QuartzBio rapidly develops virtual Master Sample Inventories in ongoing studies, providing cloud-based visibility and capturing required COVID-19 impact documentation.

Please know we are here to help and remain steadfast in our commitment to helping to keep science moving forward.

The Precision Team

Media Contact Information: